CARESCAPE Respiratory Modules Recalled Over Potentially Dangerous Oxygen Levels

Federal health officials indicate that some GE Healthcare respiratory monitors may display inaccurate patient oxygen levels, which could increase the risk of organ damage, infection or death.

A CARESCAPE Respiratory Module recall was announced by the FDA on February 4, due to a manufacturing defect that may cause the devices to display incorrect oxygen values, leading to high or low blood oxygen levels in the patient. No injuries or deaths have been linked to the recalled monitors, according to the agency.

The CARESCAPE Respiratory Modules and Airway Gas Options are respiratory accessories used in the healthcare setting to monitor adults, pediatric and neonatal ventilation activity. The devices measure respiratory gases such as oxygen and carbon dioxide, anesthesia, and breathing characteristics to ensure patients are receiving the appropriate course of treatment.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

According to the recall, a defect in the design of the monitoring devices could calculate and display incorrect oxygen values, causing long-term high or low blood oxygen levels. The agency warns these incidents could result in serious adverse health consequences for patients including organ damage, tissue injury, increased chance of infection, or death.

The recall includes Airway Gas Option N-CAiO, and CARESCAPE Respiratory Modules with model numbers E-sCO,  sCOVX, E-sCAiO, E-sCAiOV, E-sCAiOE, and E-sCAiOVE. The devices were manufactured by GE Healthcare of Chicago, Illinois from June 7, 2019 through August 16, 2019 and were distributed for sale to healthcare facilities across the United States.

The FDA warns customers that the medical devices can deteriorate over time, and should be checked on a daily basis to ensure the modules are within specification.

On September 27, 2019, GE Healthcare issued a medical device warning to customers informing them of the issue, with instructions on how to replace the impacted Airway Gas Option and CARESCAPE respiratory modules. GE provided customers instructions on how to request a replacement module if one was not available at no cost.

The FDA has classified the recall with a Class I status, indicating it is the most serious type of recall. Class I recalls involve products in which there is a reasonable probability that the use of the product will cause serious adverse health consequences or death.

Customers with impacted CARESCAPE or Airway Gas Option modules are encouraged to contact GE Healthcare Services at 1-800-437-1171 for any further questions.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer
Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer "Representative" (Posted 3 days ago)

Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.